Status: Approved
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Hepatitis; Hepatitis C Phase 1/Phase 2 ClinicalTrials
Lymphopenia; T-Lymphocytopenia, Idiopathic CD4-Positive Phase 1/Phase 2 ClinicalTrials
Sepsis; Toxemia Phase 2 ClinicalTrials
Breast Neoplasms; Lymphopenia Phase 2 ClinicalTrials
Sepsis; Toxemia Phase 2 ClinicalTrials
HIV Infections Phase 1 ClinicalTrials
Hepatitis; Hepatitis C Phase 1/Phase 2 ClinicalTrials
Sepsis; Toxemia Phase 2 ClinicalTrials
Hepatitis; Hepatitis C Phase 1/Phase 2 ClinicalTrials
Lymphoma; Lymphoma, B-Cell Phase 4 ClinicalTrials
CONTENTS